Navigation Links
Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
Date:10/19/2007

NATICK, Mass., Oct. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2007, as well as guidance for net sales and earnings per share (EPS) for the fourth quarter of 2007.

Highlights

- Reported net sales of $2.048 billion, which was at the mid-point of

guidance, and adjusted EPS of $0.20, which exceeded guidance

- Attained number one position in the worldwide drug-eluting stent (DES)

market

- Achieved DES market share leadership in Japan

- Reached 56 percent market share in the U.S. DES market, up from

54 percent last quarter

- Reported year-over-year worldwide cardiac rhythm management (CRM) sales

growth of 16 percent, including implantable cardioverter defibrillator

(ICD) growth of 18 percent

- Announced several new initiatives designed to increase shareholder

value, including the planned sale of business units, and expense and

head count reductions

- Amended the Company's term loan agreement, providing increased

financial flexibility, while prepaying $1 billion of the loan

Net sales for the third quarter of 2007 were $2.048 billion as compared to $2.026 billion for the third quarter of 2006. Worldwide sales of the Company's drug-eluting coronary stent systems for the third quarter of 2007 were $448 million as compared to $572 million for the third quarter of 2006. U.S. sales of drug-eluting coronary stent systems for the third quarter of 2007 were $240 million as compared to $384 million for the third quarter of 2006. International sales of drug-eluting coronary stent systems were $208 milli
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. The birth of biotech: San Francisco, Boston, Geneva or Chicago?
2. Wicab to present BrainPort at Boston conference
3. Boston equity firm becomes majority owner of Cedarburg-based Mortgagebot
4. Boston entrepreneur to enliven Milwaukee angel group
5. UW-Madisons Beebe wins scientific award
6. Researchers say scientific reporting needs more perspective, less hype
7. Wisconsin stands at the center of scientific efforts to avert flu epidemics
8. Growth prompts new location for scientific instrument manufacturer
9. UW stem cell guru outlines scientific and political future
10. Wisconsin biotech sector featured in scientific magazine
11. Scientific Protein Laboratories Acquired by New York firm

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...NCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall...day announced revenue guidance for the fourth quar...illion, as compared with $69 million for the fourt... results was the first of two installment payments...fourth quarter 2008 results was a one-time $1.8 mi...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 To...dustry and to promote its potential, a group of in... the Synthetic Biology Industry Association (SynBI... of the association is to provide a forum for indi...w industry, address its opportunities and its chal...
(Date:12/1/2009)...SAN FRANCISCO, Dec. 1 The Burrill ...alf the value it lost in October. The Select,s gai...nt month for the general markets with the Dow up 6... The gains held firm in the final two trading days...ish Thanksgiving holiday shopping and Dubai,s repo...
(Date:12/1/2009)... , SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ ...) announced today that it will present at the LD M...:00 p.m. (PST) at the Luxe Hotel in Los Angeles. A... will present a corporate overview and will provid... its lead product, the Hemopurifier®, a first...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2
.... 29 Allos,Therapeutics, Inc. (Nasdaq: ALTH ), a...ent and commercialization of small molecule therap...d that members of the Company,s,senior management ...ill,Lynch Global Pharmaceutical, Biotechnology and...any,s presentation will take place at 11:00 a.m. (...
...swire/ - Viventia Biotech Inc., a privately held,b...novel antibody,therapeutics focused on cancer, ann...natives to further advance and realize value from ...dy discovery platform and its,antibody manufacturi...al,strategic opportunities including, but not limi...
...to Canadian HAI Market; Market Expenditures for MR...llion by 2012, SUNNYVALE, Calif., Jan. 29 Cephei...a has issued a medical device,license for the Xper...llin,Resistant Staphylococcus aureus (MRSA) on nas...est results are available in approximately 70 minu...
Other Biology Technology:Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 2Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 3Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 4Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 5Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 6Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 2Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 3Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 4
(Date:12/1/2009)...Ben-Ari, winner of the 2009 Inserm Grand Prix., ...mitment to paying tribute to outstanding,work per...ouring talents, Inserm intends to,demonstrate the...day,s biological, medical and,health research, an...who carry out and,drive this research each day. T...
(Date:12/1/2009)...LE, Fla. Hit-and-run attacks by sharks can be sol...its by the unique chomp they put on their victims,...nd shark expert. , In a method analogous to anal...tifications by precisely comparing shark bites to ... George Burgess, director of the International Sha...
(Date:12/1/2009)...d first, a Monash University-led international res...t the output of the next generation of solar cells...ation with colleagues from the universities of Wol...ye-sensitised solar cells with a three-fold increa...reviously reported tandem dye-sensitised solar cel...
Breaking Biology News(10 mins):Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Innovation puts next-generation solar cells on the horizon 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 1VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 2VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 3Accumetrics Inc Announces Distribution Channels in Israel and Cyprus 48302 1Accumetrics Inc Announces Distribution Channels in Israel and Cyprus 48302 2
...w research shows that we should be looking to the ...ould have its most perilous impact on life on Eart...borough have published research findings in the pr...global warming actually changes the molecular stru...s more than twice the amount of carbon than does t...
...new study by Narendra et al. suggests that Parkin,...ne Park2, prompts neuronal survival by clearing th... an exciting new discovery that links the fields o...f Parkinson,s disease (PD)," writes Heidi McBride ... work significantly increases our understanding of...
...lacksburg, Va. An international consortium of res...e of the domesticated turkey, Meleagris gallopavo....che GS-FLX sequencing platform and the recently la... and reagents. , The new upgrade to the Roche GS... individual sequencing reads to be generated for e...
Other Biology News:Global warming is changing organic matter in soil 2Research consortium to sequence turkey genome 2Research consortium to sequence turkey genome 3Research consortium to sequence turkey genome 4
...uct has been developed to significantly increase t...ns. Stability is increased at room temperature st...his product is subjected to 0.45 micron filtration...ion insures consistently high levels of activity f...
...atic I provides a convenient and affordable altern... Used with an eight-port disposable manifold, the ...ible with multi-channel pipettes. The eight-port m...s fluids in volumes of 100, 200, 250, or 300mL wit...
Corning brand cover glass squares, 0.16 to 0.19mm thick from Sigma-Aldrich
...ilm Life Science FLA-8000 Fluorescent Image Analyz...ection in a single laser imaging system. This powe...labeled with fluorescent dyes or radioisotopes at ...g laboratories. Speed, image quality and flexibili...
Biology Products: